Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Nova Pneuma

    • Home
    • Nova Pneuma
Company Deals

Lee’s Pharm Staccato-OBT Acquisition Bolsters UCB Partnership

Fineline Cube Dec 10, 2025

Lee’s Pharmaceutical Holdings Limited (HKG: 0950) announced that its wholly‑owned subsidiary Nova Pneuma Inc. (NPI)...

Recent updates

  • Lee’s Pharm Staccato-OBT Acquisition Bolsters UCB Partnership
  • Zhaoke BRIMOCHOL-PF Taiwan License Targets Presbyopia Market
  • Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval
  • Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy
  • Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Deals

Lee’s Pharm Staccato-OBT Acquisition Bolsters UCB Partnership

Company Deals

Zhaoke BRIMOCHOL-PF Taiwan License Targets Presbyopia Market

Company Drug

Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval

Company Drug

Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.